6QC0 image
Deposition Date 2018-12-25
Release Date 2019-01-23
Last Version Date 2024-05-15
Entry Detail
PDB ID:
6QC0
Keywords:
Title:
PCNA complex with Cdt2 C-terminal PIP-box peptide
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.50 Å
R-Value Free:
0.25
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 61
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Proliferating cell nuclear antigen
Gene (Uniprot):PCNA
Chain IDs:A, B (auth: C), C (auth: E)
Chain Length:263
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Denticleless protein homolog
Gene (Uniprot):DTL
Chain IDs:D (auth: B), E (auth: D), F
Chain Length:14
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Direct binding of Cdt2 to PCNA is important for targeting the CRL4Cdt2E3 ligase activity to Cdt1.
Life Sci Alliance 1 e201800238 e201800238 (2018)
PMID: 30623174 DOI: 10.26508/lsa.201800238

Abstact

The CRL4Cdt2 ubiquitin ligase complex is an essential regulator of cell-cycle progression and genome stability, ubiquitinating substrates such as p21, Set8, and Cdt1, via a display of substrate degrons on proliferating cell nuclear antigens (PCNAs). Here, we examine the hierarchy of the ligase and substrate recruitment kinetics onto PCNA at sites of DNA replication. We demonstrate that the C-terminal end of Cdt2 bears a PCNA interaction protein motif (PIP box, Cdt2PIP), which is necessary and sufficient for the binding of Cdt2 to PCNA. Cdt2PIP binds PCNA directly with high affinity, two orders of magnitude tighter than the PIP box of Cdt1. X-ray crystallographic structures of PCNA bound to Cdt2PIP and Cdt1PIP show that the peptides occupy all three binding sites of the trimeric PCNA ring. Mutating Cdt2PIP weakens the interaction with PCNA, rendering CRL4Cdt2 less effective in Cdt1 ubiquitination and leading to defects in Cdt1 degradation. The molecular mechanism we present suggests a new paradigm for bringing substrates to the CRL4-type ligase, where the substrate receptor and substrates bind to a common multivalent docking platform to enable subsequent ubiquitination.

Legend

Protein

Chemical

Disease

Primary Citation of related structures